pfizer

Welcome to the 'pfizer' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'pfizer'.

Are you an expert about 'pfizer'? Do you want to be the Technorati authority on 'pfizer'? You can write a description that will appear right here: Join Blogcritics!

Original Technorati articles tagged “pfizer”

• in Business
  Drugmakers To Access Patient Data For $50,000 To $200,000 Per Search
  Five large pharmaceutical companies hope to more effectively find candidates for their drug trials
  by savingadvice / on Nov 15, 2011
• in Technology
  Pfizer to Start Stem Cell Clinical Trials on Humans
  Pfizer is now ready to start clinical trials of stem cell treatment on humans. How will the opponents to stem cell research react to this?
  by jobertv / on Oct 10, 2011
• in Business
  Leadership and Real Leadership
  Deniers who learn to become trust builders.
  by sylvialafairphd / on Sep 14, 2011

Latest blogosphere posts tagged “pfizer”

 

• Pfizer Inc. (PFE), Puma Biotechnology Inc (PBYI): Strong Product Pipelines Have Pharmaceutical Companies Poised for Growth

  
  — Authority:
  With the global economy beginning to stabilize, the stock market is looking more attractive than ever. One industry that could stand to make huge gains in the near future is the pharmaceutical industry, though it’s worth noting that this sector is a high risk, high reward industry. Still, pharmaceutical stocks offer ...
  5 days ago

• Pfizer reaches $2.15 billion settlement in patent infringement battle

  
  Detroit Business News — Authority: 781
  Pfizer and Takeda are will receive $2.15 billion after a jury determined two pharmaceutical companies violated a patent for Protonix acid reflux disease treatment.
  5 days ago

• Is Merck the Best Option In This Group?

  
  — Authority:
  With shares of Merck ( NYSE:MRK ) trading at around $47.56, is MRK an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : C = Catalyst for the Stock ’s Movement An FDA panel recently voted for approval of Suvorexant (insomnia). ...
  6 days ago

• AstraZeneca plc (ADR) (AZN), Novartis AG (ADR) (NVS): 5 Biotech Giants with Lucrative Dividend Yields

  
  — Authority:
  Investing in biotech stocks is relatively risky amid the volatility of the market. There are many factors that can greatly affect share trends and price performance. Biotech companies go through a series of clinical trials toward FDA approval and market launch. Any update of the trial can potentially cause the shares ...
  6 days ago

• Brahman Capital Owns 5.7% of Endo Health Solutions Inc (ENDP)

  
  — Authority:
  A 13G filed with the SEC has disclosed that Brahman Capital, a hedge fund managed by Peter Hochfelder and his team, owns 6.3 million shares of Endo Health Solutions Inc (NASDAQ: ENDP ) , a $4.3 billion market cap pharmaceutical company. We track quarterly 13F filings from hedge funds such as Brahman as part of our ...
  6 days ago

• FT Healthcare Conference: Society as Stakeholder

  
  — Authority:
  Speakers at the 2 nd annual Financial Times US Healthcare and Life Sciences conference in New York last week discussed the cost of health, and the implications of an increasingly vocal and influential stakeholder group: the local populace. After opening remarks from Andrew Jack, FT ’s prolific ...
  6 days ago

• Teva to pay out $1.6 Billion to Pfizer and Takeda in Damages for Infringing Patent for Protonix.

  
  The IP Factor — Authority: 412
  Protonix is a heartburn treatment that was developed and patented by Nycomed which was later purchased by Japan’s Takeda Pharmaceutical Co.  Nycomed had licensed Protonix to Wyeth, which Pfizer subsequently  purchased. Israel’s Teva Pharmaceutical Industries Ltd. and India’s Sun Pharmaceutical Industries ...
  1 week ago

• CEO of RBS Steps Down, Pandora Escapes Royalties: Market Recap

  
  — Authority:
  U.S. stocks had a turbulent day, but ultimately ended on the low side, with the Nasdaq falling 1 percent by the time markets closed. The housing market did bring some good news though, as the latest reports have shown a 10.9 percent increase in home prices in the first quarter, along with a decline in the number of ...
  1 week ago

• Microsoft Corporation (MSFT), Hewlett-Packard Company (HPQ), Pfizer Inc. (PFE): 3 Stocks Defying the Dow’s Drop

  
  — Authority:
  The Dow Jones Industrial Average is following markets in Asia and Europe lower today. As of 1:20 p.m. EDT the Dow is down 58 points, or 0.39%, to 15,064. The S&P 500 is down 0.38% to 1,620. There were no U.S. economic releases today. The Dow opened 100 points higher before falling nearly 200 points to where ...
  1 week ago

• Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Does This Pipeline Promise Tomorrow’s Blockbuster Sales?

  
  — Authority:
  Nearly every big pharma player has been hit with patent expirations that have hit hard on sales lately, and Merck & Co., Inc. (NYSE: MRK ) is no exception. Merck & Co., Inc. (NYSE:MRK)’s one of the industry’s biggest giants, but the loss of patent protection on former top blockbuster drug Singulair and ...
  1 week ago

• Aggressive Tactics Proved Too Risky For These Generic Drugmakers

  
  — Authority:
  Teva Pharmaceutical ( NYSE:TEVA ) and Sun Pharmaceutical made a surprising decision in late 2007: sell a low-cost generic version of Protonix before the key U.S. patent expired. This move was a bold example of the aggressive tactics used by generic-drug manufacturers to bring lower-cost copies of blockbuster ...
  1 week ago

• Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)

  
  — Authority:
  Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates.
  1 week ago

• AVEO Pharmaceuticals, Inc. (AVEO): Drug Rejected! Let’s Rejoice?

  
  — Authority:
  AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) ‘ announced yesterday that the Food and Drug Administration rejected its kidney cancer drug tivozanib. No surprise there. The briefing documents for the advisory panel meeting expressed the FDA reviewers’ negative opinion, and tivozanib’s fate was sealed when the ...
  1 week ago

• Pfizer Prevails In Infringement Suit and 2 Other Hot Stocks to Watch

  
  — Authority:
  Pfizer ( NYSE:PFE ): Current price $28.55 Pfizer shares spiked somewhat in morning trading, on word that it and Takeda Pharmaceutical had arrived at a favorable $2.15-billion settlement in its patent-infringement lawsuit against Teva Pharmaceutical Industries  ( NYSE:TEVA ) and Sun Pharmaceutical Industries. ...
  1 week ago

• VIDEO: Finance Latest News: Global Tumult Grips Markets

  
  — Authority:
  Global Tumult Grips Markets. Wall Street Rebounds. Pfizer Settles Patent Lawsuit for $2.15 Billion Thanks for checking us out. Please take a look at the rest of our videos and articles. To stay in the loop, bookmark our homepage . div#grabpreview {display:none !important;} Noir Etui Housse ...
  1 week ago

• VIDEO: Latest Business News: Stock Indexes Open Higher on Wall Street

  
  — Authority:
  Stock indexes open higher on Wall Street. HP CEO: revenue growth ‘still possible’ for fiscal 2014. Pfizer settles patent lawsuit with Teva, Sun Pharma for $2.15 billion Thanks for checking us out. Please take a look at the rest of our videos and articles. To stay in the loop, bookmark our ...
  1 week ago

• Pfizer Wins Big Settlement From Teva and 3 More Hot Stocks

  
  — Authority:
  Pfizer Inc . ( NYSE:PFE ): Pfizer and Takeda pharmaceuticals have obtained a $2.15 billion settlement from Teva ( NYSE:TEVA ) and India’s Sun for breaching a patent of Pfizer’s and  Takeda subsidiary Nycomed’s  acid reflux medicine Protonix. Pfizer will receive 64 percent of the money, while Takeda ...
  1 week ago

• Pfizer settles patent case against generic drugmakers for $2.15 billion

  
  — Authority:
  Teva Pharmaceutical Industries Ltd. will pay $1.6 billion, while Indias Sun Pharmaceutical Industries Ltd. will pay $550 million for selling their versions of Protonix before the patent protecting the drug expired.
  1 week ago

• VIDEO: Law & Crime Breaking News: Pfizer Settles Patent Lawsuit With Teva, Sun Pharma for $2.15 Billion

  
  — Authority:
  Post at TOBIASRENFROE.COM Pfizer settles patent lawsuit with Teva, Sun Pharma for $2.15 billion. Feds: Morning-after pill appeal officially on hold. Chris Brown given five weeks to resolve community service dispute ...
  1 week ago

• VIDEO: Breaking News Headlines: Pfizer Settles Patent Lawsuit With Teva, Sun Pharma for $2.15 Billion

  
  — Authority:
  Post at TOBIASRENFROE.COM Pfizer settles patent lawsuit with Teva, Sun Pharma for $2.15 billion. Volkswagen recalls almost 26,000 cars in Australia. Poll Finds Disapproval of Record Collection, But Little Personal Concern ...
  1 week ago

Comments about pfizer